13-108286850-A-G
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_006573.5(TNFSF13B):c.472A>G(p.Ile158Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_006573.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TNFSF13B | NM_006573.5 | c.472A>G | p.Ile158Val | missense_variant | 3/6 | ENST00000375887.9 | NP_006564.1 | |
TNFSF13B | XM_047430055.1 | c.472A>G | p.Ile158Val | missense_variant | 3/5 | XP_047286011.1 | ||
TNFSF13B | NM_001145645.2 | c.425-16403A>G | intron_variant | NP_001139117.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TNFSF13B | ENST00000375887.9 | c.472A>G | p.Ile158Val | missense_variant | 3/6 | 1 | NM_006573.5 | ENSP00000365048 | P1 | |
TNFSF13B | ENST00000542136.1 | c.472A>G | p.Ile158Val | missense_variant | 3/4 | 1 | ENSP00000445334 | |||
TNFSF13B | ENST00000430559.5 | c.425-16403A>G | intron_variant | 1 | ENSP00000389540 | |||||
TNFSF13B | ENST00000479435.1 | n.246A>G | non_coding_transcript_exon_variant | 2/5 | 3 |
Frequencies
GnomAD3 genomes Cov.: 31
GnomAD4 exome Cov.: 29
GnomAD4 genome Cov.: 31
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 02, 2022 | The c.472A>G (p.I158V) alteration is located in exon 3 (coding exon 3) of the TNFSF13B gene. This alteration results from a A to G substitution at nucleotide position 472, causing the isoleucine (I) at amino acid position 158 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.